U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
120031120031Sleep Disturbance and Bipolar DisorderCompletedNo Results AvailableBipolar Disorder|DyssomniasBehavioral: Cognitive behavioral therapy for insomnia|Other: Bipolar educationhttps://ClinicalTrials.gov/show/NCT00993850
120032120032Feasibility of Endoscopic Thyroidectomy for Thyroid CarcinomaNot yet recruitingNo Results AvailableThyroid CarcinomaProcedure: thyroidectomyhttps://ClinicalTrials.gov/show/NCT00993837
120033120033Glycemic Effect of Colesevelam HCl (Welchol) in Patients With Type 2 DiabetesCompletedHas ResultsType 2 DiabetesDrug: colesevelam HCl|Drug: placebohttps://ClinicalTrials.gov/show/NCT00993824
120034120034The Shang Ring: A Novel Male Circumcision Device for HIV PreventionCompletedNo Results AvailableMale Circumcision|HIV Prevention|HIV InfectionsDevice: Shang Ring circumcisionhttps://ClinicalTrials.gov/show/NCT00993811
120035120035An International Trial to Evaluate the Efficacy and Safety of SABER-Bupivacaine for Postoperative Pain Control in Patients Following Arthroscopic Shoulder SurgeryCompletedNo Results AvailablePostoperative PainDrug: SABER-Bupivacaine Treatment 1a|Drug: Placebo SABER-Bupivacaine Treatment 1b|Drug: Bupivacaine HCl Treatment 1c|Drug: SABER-Bupivacaine Treatment 2a|Drug: Placebo SABER-Bupivacaine Treatment 2b|Drug: Bupivacaine HCl Treatment 2chttps://ClinicalTrials.gov/show/NCT00993798
120036120036CoStar Catheter System EvaluationTerminatedNo Results AvailableSymptomatic Ischemic Heart DiseaseDevice: Costar Coronary Stent Delivery Systemhttps://ClinicalTrials.gov/show/NCT00993785
120037120037[Trial of device that is not approved or cleared by the U.S. FDA]WithheldNo Results Availablehttps://ClinicalTrials.gov/show/NCT00993772
120038120038Efficacy Study of A Lotion to Prevent Common ColdsActive, not recruitingNo Results AvailableCommon Cold|HealthyDrug: 3804-250Ahttps://ClinicalTrials.gov/show/NCT00993759
1200391200392% Lidocaine Plus 0.5% Bupivacaine Versus 0.5% Bupivacaine in Brachial Block for Creation of Arteriovenous (AV) FistulaRecruitingNo Results AvailableInfraclavicular Brachial Plexus BlockDrug: Bupivacaine plus lidocaine|Drug: Bupivacaine 30 mlhttps://ClinicalTrials.gov/show/NCT00993746
120040120040Assessing the Impact of Two Methods of Continuous Veno-venous Hemodiafiltration on Time Nursing Work in Intensive CareWithdrawnNo Results AvailableAcute Renal FailureProcedure: Continuous veno-venous haemodiafiltrationhttps://ClinicalTrials.gov/show/NCT00993733
120041120041Effect of GLP-1 on Insulin-dose, Risk of Hypoglycemia and Gastric Emptying Rate in Patients With Type 1 DiabetesCompletedNo Results AvailableDiabetes MellitusDrug: Liraglutide|Drug: Liraglutide|Other: continuous insulin therapyhttps://ClinicalTrials.gov/show/NCT00993720
120042120042Safety Study of CTX-100 Inhalation Solution (Formerly ETX-100)RecruitingNo Results AvailableChronic Obstructive Pulmonary Disease (COPD)Drug: CTX-100 (formerly ETX-100) (hyaluronic acid)https://ClinicalTrials.gov/show/NCT00993707
120043120043Methemoglobinemia in Young Patients With Hematologic Cancer or Aplastic Anemia Treated With DapsoneCompletedNo Results AvailableChronic Myeloproliferative Disorders|Leukemia|Lymphoma|Lymphoproliferative Disorder|Methemoglobinemia|Multiple Myeloma and Plasma Cell Neoplasm|Myelodysplastic Syndromes|Myelodysplastic/Myeloproliferative Neoplasms|Nonmalignant NeoplasmDrug: chemotherapy|Drug: dapsone|Other: medical chart review|Procedure: assessment of therapy complicationshttps://ClinicalTrials.gov/show/NCT00993694
120044120044Travelers' Diarrhea (TD) Vaccine Pivotal Efficacy StudyCompletedNo Results AvailableTravelers' DiarrheaBiological: TD Vaccine System|Biological: TD Vaccine Systemhttps://ClinicalTrials.gov/show/NCT00993681
120045120045Assessing the Use of Certolizumab Pegol in Adult Subjects With Rheumatoid Arthritis on the Antibody Response When Receiving Influenza Virus and Pneumococcal VaccinesCompletedHas ResultsRheumatoid ArthritisOther: Placebo|Biological: Certolizumab pegolhttps://ClinicalTrials.gov/show/NCT00993668
120046120046Comparing Combination Chemotherapy Regimens in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube CancerActive, not recruitingNo Results AvailableFallopian Tube Cancer|Metastatic Cancer|Ovarian Cancer|Peritoneal Cavity CancerDrug: carboplatin|Drug: cisplatin|Drug: paclitaxel|Procedure: quality-of-life assessmenthttps://ClinicalTrials.gov/show/NCT00993655
120047120047ERB-B4 After Treatment With HDAC Inhibitor in ER+ Tamoxifen Refractory Breast CancerTerminatedNo Results AvailableBreast CancerDrug: Panobinostat (LBH589)https://ClinicalTrials.gov/show/NCT00993642
120048120048Adjunctive Pregnenolone in Post-Traumatic Stress Disorder (PTSD) and Depression in Operations Enduring Freedom and Iraqi Freedom (OEF/OIF) VeteransWithdrawnNo Results AvailablePost-traumatic Stress Disorder|Major Depressive DisorderDrug: pregnenolone|Drug: placebohttps://ClinicalTrials.gov/show/NCT00993629
120049120049Belinostat and Carboplatin in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Did Not Respond to Carboplatin or CisplatinCompletedHas ResultsBrenner Tumor|Fallopian Tube Cancer|Ovarian Clear Cell Cystadenocarcinoma|Ovarian Endometrioid Adenocarcinoma|Ovarian Mixed Epithelial Carcinoma|Ovarian Mucinous Cystadenocarcinoma|Ovarian Serous Cystadenocarcinoma|Ovarian Undifferentiated Adenocarcinoma|Drug: belinostat|Drug: carboplatinhttps://ClinicalTrials.gov/show/NCT00993616
120050120050Lifestyle Intervention in Obese Non-diabetic Adults With a Family History of Diabetes.CompletedNo Results AvailableType 2 Diabetes|ObesityBehavioral: 8-month group lifestyle programmehttps://ClinicalTrials.gov/show/NCT00993603
120051120051Mobile CHESS Research on Emergency Medical Services for ChildrenCompletedNo Results AvailableAsthmaBehavioral: M CHESShttps://ClinicalTrials.gov/show/NCT00993590
120052120052Stretching Exercises and Temporomandibular DisordersCompletedNo Results AvailableTemporomandibular DisordersOther: Stretching exercises|Device: Stretching exercises|Device: Exerciseshttps://ClinicalTrials.gov/show/NCT00993577
120053120053Magnetic Resonance Imaging (MRI) Thermal Imaging of Infants Undergoing Cooling for Hypoxic Ischemic Encephalopathy (HIE)WithdrawnNo Results AvailableHypoxic Ischemic Encephalopathyhttps://ClinicalTrials.gov/show/NCT00993564
120054120054Timing of Primary Surgery for Cleft PalateRecruitingNo Results AvailableCleft PalateProcedure: primary surgery for cleft palatehttps://ClinicalTrials.gov/show/NCT00993551
120055120055Leukemia Cell Cultures for Research of New Anti-Cancer TherapiesRecruitingNo Results AvailableAcute LeukaemiaProcedure: Blood sampling|Procedure: Bone marrow aspirationhttps://ClinicalTrials.gov/show/NCT00993538
120056120056Intravitreal Ranibizumab For Persistent New Vessels In Diabetic Retinopathy(Inipe Study)Active, not recruitingNo Results AvailableProliferative Diabetic RetinopathyDrug: Intravitreal injection of ranibizumabhttps://ClinicalTrials.gov/show/NCT00993525
120057120057Safety Study of Amphinex Based Photochemical Internalisation (PCI) of Bleomycin in Patients With Cutaneous CancerCompletedNo Results AvailableHead and Neck Neoplasms|Skin NeoplasmsDrug: Amphinex (TPCS2a)|Drug: Bleomycin|Other: Illumination with CeramOptec laserhttps://ClinicalTrials.gov/show/NCT00993512
120058120058Trial of Continuous Once Daily Oral Treatment Using BIBW 2992 (Afatinib) Plus Sirolimus (Rapamune®) in Patients With Non-small Cell Lung Cancer Harbouring an EGFR Mutation and/or Disease Progression Following Prior Erlotinib or GefitinibCompletedNo Results AvailableCarcinoma, Non-Small-Cell LungDrug: BIBW 2992|Drug: Sirolimus (rapamycin)https://ClinicalTrials.gov/show/NCT00993499
120059120059Dose-ranging Study of a Single Administration of T-cell Add-back Depleted of Host Alloreactive Cells in Patients Undergoing a Peripheral Blood Stem Cell Transplant From a Related, Haploidentical DonorCompletedNo Results AvailableHematologic Diseases|Hematologic MalignanciesBiological: Donor lymphocyte preparation depleted of functional host alloreactive T-cells (ATIR)https://ClinicalTrials.gov/show/NCT00993486
1200601200606-month Comparison of Morning Lantus Versus Neutral Protamine Hagedorn Insulin in Young Children With Type 1 DiabetesCompletedHas ResultsType 1 Diabetes MellitusDrug: Insulin glargine (HOE901)|Drug: Neutral Protamine Hagedorn (NPH) insulin|Drug: Insulin lisprohttps://ClinicalTrials.gov/show/NCT00993473

* Görseller ve İçerik tekif hakkına sahip olabilir